Survival in patients with advanced renal cell carcinoma in the era of immunotherapies: first data from the German research platform CARAT 10. November 2023 Goebell P.J., Bögemann M., Nusch A., Grünwald V., Müller L., von der Heyde E., Reichert D., Martens U.M., Grüllich C., Staehler M., Wetzel N., Koska M., Jänicke M., Marschner N., Potthoff K. Oncol Res Treat. 2023;46 (Suppl. 5)(V510):76-77 Link Routine care of patients with resectable gastric (GC) and gastroesophageal junction (GEJC) adenocarcinoma – Data of the retrospective perioperative cohort PRIME of the registry platform SAPHIR Lordick F., Dechow T., von der Heyde E., Sadjadian P., Schulte C., de Buhr R., Lennartz C., Binninger A., Jänicke M., Kruger S., Abromeit M.,… Weiterlesen Evaluation of the metastatic colorectal cancer score (mCCS) in predicting outcome for patients with RAS wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Updated interim results of the non-interventional study VALIDATE Reiser M, Marschner N, Uhlig J, Jacobasch L, Müller L, Schuch A, Serrer L, de Buhr RK, Siebenbach HU, Göhler T, Schröder J, Semsek D,… Weiterlesen